List of substances in Schedule II Verdrag inzake psychotrope stoffen
International non-proprietary name (INN) | Other non-proprietary or trivial names | Chemical name
α-Pyrrolidinovalerophenone, α-PVP | 1-Phenyl-2-(pyrrolidin-1-yl)pentan-1-one
AB-CHMINACA | N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
AB-FUBINACA | N-[1-Amino-3-methyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide
AB-PINACA | N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-pentyl-1H-indazole-3-carboxamide
ADB-BUTINACA | N-[1-(Aminocarbonyl)-2,2-dimethylpropyl]-1-butyl-1H-indazole-3-carboxamide
ADB-CHMINACA (MAB-CHMINACA) | N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
ADB-FUBINACA | N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide
alpha-PiHP | 4-Methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one
alpha-PHP | 1-Phenyl-2-(pyrrolidin-1-yl)hexan-1-one
AM-2201 | 1-(5-Fluoropentyl)-1H-indol-3-yl]-(naphthalen-1-yl)methanone
Amfetamine | Amphetamine | (±)-α-Methylphenethylamine
Amineptine | | 7-[(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid
N-Benzylpiperazine, BZP | 1-Benzylpiperazine
2C-B | 4-Bromo-2,5-dimethoxyphenethylamine
3--Chloromethcathinone (3-CMC) | 1-(3-Chlorophenyl)-2-(methylamino)propan-1-one
4-CMC (4-chloromethcathinone, clephedrone) | 1-(4-Chlorophenyl)-2-(methylamino)propan-1-one
CUMYL-4CN-BINACA | 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide
CUMYL-PEGACLONE | 5-Pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one
Dexamfetamine | Dexamphetamine | (+)-α-Methylphenethylamine
Dipentylone | 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one
Diphenidine | 1-(1,2-Diphenylethyl)piperidine
Dronabinol* | delta-9-Tetrahydro-cannabinol and its stereochemical variants | (6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d] pyran-1-ol
N-Ethylhexedrone | 2-(Ethylamino)-1-phenylhexan-1-one
N-Ethylnorpentylone (ephylone) | 1-(2H-1,3-Benzodioxol-5-yl)-2-(ethylamino)pentan-1-one
Ethylone | 1-(2H-1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-one
Ethylphenidate | Ethyl phenyl(piperidin-2-yl)acetate
Eutylone | 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)butan-1-one
4-Fluoroamphetamine (4-FA) | 1-(4-Fluorophenyl)propan-2-amine
2-Fluorodeschloroketamine | 2-(2-Fluorophenyl)-2-(methylamino)cyclohexan-1-one
4F-MDMB-BINACA | Methyl 2-{[1-(4-fluorobutyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate
5F-AMB-PINACA (5F-AMB, 5F-MMB-PINACA) | Methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3-methylbutanoate
5F-APINACA (5F-AKB-48) | N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide
5F-MDMB-PICA (5F-MDMB-2201) | Methyl 2-{[1-(5-fluoropentyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate
5F-MDMB-PINACA (5F-ADB), | Methyl (2S)-2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate
Fenetylline | | 7-[2-[(α-Methylphenethyl)amino]ethyl]theophylline
5F-PB-22 | Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate
FUB-AMB (MMB-FUBINACA, AMB-FUBINACA) | Methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoate
GHB | γ-Hydroxybutyric acid
Hexahydrocannabinol, HHC | 6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol
JWH-018 | Naphthalen-1-yl(1-pentyl-1H-indol-3-yl)methanone
Levamfetamine | Levamphetamine | (-)-(R)-α-Methylphenethylamine
Levomethamphetamine | (-)-N,α-Dimethylphenethylamine
MDMB-CHMICA | Methyl N-{[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl}-3-methyl-L-valinate
MDMB-4en-PINACA | Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate
Mecloqualone | | 3-(o-Chlorophenyl)-2-methyl-4(3H)-quinazolinone
Mephedrone, 4-methylmethcathinone | (RS)-2-(Methylamino)-1-(4-methylphenyl)propan-1-one
Metamfetamine | Methamphetamine | (+)-(S)-N,α-Dimethylphenethylamine
Metamfetamine racemate | Methamphetamine racemate | (±)-N,α-Dimethylphenethylamine
Methaqualone | | 2-Methyl-3-o-tolyl-4(3H)-quinazolinone
Methiopropamine (MPA) | N-Methyl-1-(thiophen-2-yl)propan-2-amine
Methoxetamine, MXE | 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone
3-Methoxyphencyclidine | 1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine
3,4-Methylenedioxypyro-valerone, MDPV | (RS)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one
4-Methylethcathinone (4-MEC) | 2-(Ethylamino)-1-(4-methylphenyl) propan-1-one
3-Methylmethcathinone | 2-(Methylamino)-1-(3-methylphenyl)propan-1-one
Methylone, beta-keto-MDMA | (RS)-2-Methylamino-1-(3,4-methylenedioxyphenyl)propan-1-one
Methylphenidate | | Methyl α-phenyl-2-piperidine acetate
para-Methyl-4-methylaminorex, 4,4’-DMAR | 4-Methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine
Pentedrone | 2-(Methylamino)-1-phenylpentan-1-one
Phencyclidine | PCP | 1-(1-Phenylcyclohexyl)piperidine
Phenmetrazine | | 3-Methyl-2-phenylmorpholine
Secobarbital | | 5-Allyl-5-(1-methylbutyl)barbituric acid
UR-144 | 1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone
XLR-11 | [1-(5-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl) methanone
Zipeprol | | α-(α-Methoxybenzyl)-4-(β-methoxyphenethyl)-1-piperazineethanol
The salts of the substances listed in this Schedule whenever the existence of such salts is possible.
* This INN refers to only one of the stereochemical variants of delta-9-tetrahydrocannabinol, namely (-)-trans-delta-9-tetrahydrocannabinol.
- Regeling
- Verdrag inzake psychotrope stoffen
- Soort
- Verdrag
- Geldend vanaf
- 06-12-2025
- BWB-id
- BWBV0003922
- Versie
- 2025-12-06_0